PT3687558T - Metabolic biomarkers for predicting responsiveness to fgf-18 compound - Google Patents

Metabolic biomarkers for predicting responsiveness to fgf-18 compound

Info

Publication number
PT3687558T
PT3687558T PT187820147T PT18782014T PT3687558T PT 3687558 T PT3687558 T PT 3687558T PT 187820147 T PT187820147 T PT 187820147T PT 18782014 T PT18782014 T PT 18782014T PT 3687558 T PT3687558 T PT 3687558T
Authority
PT
Portugal
Prior art keywords
fgf
compound
predicting responsiveness
metabolic biomarkers
biomarkers
Prior art date
Application number
PT187820147T
Other languages
Portuguese (pt)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PT3687558T publication Critical patent/PT3687558T/en

Links

PT187820147T 2018-04-25 2018-09-28 Metabolic biomarkers for predicting responsiveness to fgf-18 compound PT3687558T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18169324 2018-04-25

Publications (1)

Publication Number Publication Date
PT3687558T true PT3687558T (en) 2022-06-20

Family

ID=62063439

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187820147T PT3687558T (en) 2018-04-25 2018-09-28 Metabolic biomarkers for predicting responsiveness to fgf-18 compound

Country Status (1)

Country Link
PT (1) PT3687558T (en)

Similar Documents

Publication Publication Date Title
EP3857893A4 (en) Bandwidth control methods for inter prediction
SG11202104480RA (en) Interpolation for inter prediction with refinement
SG11202102794UA (en) Controlling access to multi-granularity data
IL273613A (en) Metabolic biomarkers for predicting responsiveness to fgf-18 compound
EP3175242A4 (en) Quantifying monoclonal antibody therapeutics by lc-ms/ms
EP3743058A4 (en) Methods for predicting tumor response to immunotherapy
EP4067506A4 (en) Biomarker for predicting therapeutic responsiveness to immune cell therapeutic agent
SG11202105172PA (en) Biomarkers for cardiovascular events
IL241063A0 (en) Assay for predictive biomarkers
IL273574A (en) Inflammatory biomarkers for predicting responsiveness to fgf-18 compound
EP2963114A4 (en) Method for predicting responsiveness to compound inhibiting mapk signal transduction pathway
EP3272876A4 (en) Method for predicting responsiveness to phosphatidylserine synthase 1 inhibitor
PT3687558T (en) Metabolic biomarkers for predicting responsiveness to fgf-18 compound
PT3688468T (en) Inflammatory biomarkers for predicting responsiveness to fgf-18 compound
SG11202110589PA (en) Biomarkers for selinexor
EP3149473A4 (en) Metabolic biomarkers for memory loss
EP3829630A4 (en) Predictive biomarkers for an immune response
EP3825695C0 (en) Biomarkers for responders to ait
HUE063980T2 (en) Combination of markers for predicting the response to vx-001
GB201808489D0 (en) Novel biomarkers
GB201808400D0 (en) Novel biomarkers
GB201817024D0 (en) Serum biomarkers
GB201816764D0 (en) Serum biomarkers
GB201807789D0 (en) Serum biomarkers
GB201809854D0 (en) Biomarkers